Podcast

William Schaffner, MD: Preparing for the Flu Season

Author(s):

Dr. Schaffner explains how social distancing and masks could also reduce the spread of influenza.

With the coronavirus disease 2019 (COVID-19) pandemic still bearing down on the US as the influenza season approaches, there is a lot of concern about how the medical community can handle the dueling infectious diseases.

While unlike COVID-19, there is a vaccine for the flu that could cut the spread of the flu. However, the flu vaccine is not perfect and it is possible for individuals who received the vaccine to still contract the flu. The vaccine does reduce the severity of the disease and drastically decreases the mortality rate.

There is also reason for optimism that the impact of the flu might be lessened in this upcoming season. Many individuals across the country are taking extra precautions because of the pandemic, including wearing masks in public, social distancing when possible, working from home, and avoid large gatherings. While the intent of those measures was to slow the spread of COVID-19, they could have an impact in slowing the spread of the flu.

In the latest episode of DocTalk, William Schaffner, MD, Professor of Preventive Medicine in the Department of Health Policy and Professor of Medicine in the Division of Infectious Diseases at the Vanderbilt University School of Medicine, explained the importance of the flu vaccination and what he thinks could happen this winter in regard to both the flu and COVID-19.

Related Videos
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Ankeet Bhatt, MD, MBA | Credit: X.com
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
© 2024 MJH Life Sciences

All rights reserved.